45 CFR § 180 compliance
F · 50
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
3,574
Insurances with rates
2
CPT / HCPCS codes
2,751
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| S3399 | ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT | $11,272,063 | $8,454,047 | — | — | 0 |
| C9399 | BETIBEGLOGENE AUTOTEMCEL 2 X 10EXP6 TO 20 X 10EXP6 CELL/ML IV SUSP | $3,080,000 | $2,310,000 | — | — | 0 |
| Q2042 | TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION | $2,446,250 | $1,834,688 | — | — | 0 |
| Q2055 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION | $2,160,425 | $1,620,319 | — | — | 0 |
| Q2054 | LISOCABTAGENE MARALEUCEL(CD8) 1.5X TO 70X 10EXP6 CELL/ML IV SUSP(1OF2) | $2,113,045 | $1,584,784 | — | — | 0 |
| Q2041 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $2,054,850 | $1,541,138 | — | — | 0 |
| Q2053 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $2,054,850 | $1,541,138 | — | — | 0 |
| J2326 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $686,637 | $514,977 | — | — | 0 |
| A9543 | KIT FOR YTTRIUM-90-IBRITUMOMAB 3.2 MG/2 ML INTRAVENOUS | $307,938 | $230,954 | — | — | 0 |
| J9226 | HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT | $249,917 | $187,438 | — | — | 0 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $224,883 | $168,663 | — | — | 0 |
| J0223 | GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION | $222,208 | $166,656 | — | — | 0 |
| J9347 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $215,736 | $161,802 | — | — | 0 |
| C9293 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $202,725 | $152,044 | — | — | 0 |
| J1305 | EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION | $200,850 | $150,638 | — | — | 0 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $177,907 | $133,430 | — | — | 0 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $171,001 | $128,250 | — | — | 0 |
| J7330 | IMPLANT, MACI FINAL, PRODUCT ASSEMBLED, SINGLE | $156,756 | $117,567 | — | — | 0 |
| J0202 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $156,048 | $117,036 | — | — | 0 |
| A9606 | RADIUM RA 223 DICHLOR 1,100 KBQ/ML (30 MICROCURIE/ML) INTRAVENOUS SOLN | $148,063 | $111,047 | — | — | 0 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $133,462 | $100,096 | — | — | 0 |
| Q2043 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $133,364 | $100,023 | — | — | 0 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $131,667 | $98,751 | — | — | 0 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $131,154 | $98,365 | — | — | 0 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $129,891 | $97,419 | — | — | 0 |
| J9118 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $128,921 | $96,690 | — | — | 0 |
| J9348 | NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION | $116,613 | $87,460 | — | — | 0 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $116,476 | $87,357 | — | — | 0 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $114,549 | $85,912 | — | — | 0 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $112,072 | $84,054 | — | — | 0 |
| J7311 | FLUOCINOLONE 0.59 MG INTRAVITREAL IMPLANT | $105,240 | $78,930 | — | — | 0 |
| J9600 | PORFIMER 2.5 MG/ML IV SYRINGE | $105,199 | $78,899 | — | — | 0 |
| L8688 | GENERATOR, M1000-D, SENTIVA DUO | $102,756 | $77,067 | — | — | 0 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $98,446 | $73,835 | — | — | 0 |
| J0638 | CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $94,723 | $71,042 | — | — | 0 |
| A9604 | SAMARIUM SM 153 LEXIDRONAM 5,550 MBQ/3 ML INTRAVENOUS SOLUTION | $88,888 | $66,666 | — | — | 0 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $86,294 | $64,721 | — | — | 0 |
| J9321 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $84,223 | $63,167 | — | — | 0 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $83,988 | $62,991 | — | — | 0 |
| J2502 | PASIREOTIDE PAMOATE 40 MG IM SUSPENSION | $82,122 | $61,591 | — | — | 0 |
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION | $77,250 | $57,938 | — | — | 0 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $75,752 | $56,814 | — | — | 0 |
| C2624 | DELIVERY SYS, CORDELLA AND PULM ARTERY SENSOR (IDE G1900020) | $71,250 | $53,438 | — | — | 0 |
| J1628 | GUSELKUMAB 100 MG/ML SUBCUTANEOUS SYRINGE | $70,893 | $53,170 | — | — | 0 |
| 33276 | HC INSERTION PHRENIC NERVE STIMULATOR SYSTEM | $70,201 | $52,651 | — | — | 0 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $69,345 | $52,009 | — | — | 0 |
| C1824 | GENERATOR, PULSE, OPTIMIZER SMART IPG | $69,000 | $51,750 | — | — | 0 |
| A9572 | INDIUM 111-PENTETREOTIDE 3 MCI/ML-10 MCG INTRAVENOUS KIT | $66,219 | $49,664 | — | — | 0 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION | $65,655 | $49,241 | — | — | 0 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $65,058 | $48,794 | — | — | 0 |
Showing top 50 of 3,574 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.